Structure Therapeutics Insider Trades

GPCR

Track insider trading activity from Structure Therapeutics executives and directors. See which insiders are buying and selling GPCR stock.

Trades Last 12 Months

All Insider Trades for Structure Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lang Matthew COO & GC
Holding Value $8.39M 223,776 shares
Last Trade
Apr 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.7M 408,390 shares
$53.22
$37.50
Fmr Llc 10% owner, other, See Remark 1
Holding Value $103k 2,736 shares
Last Trade
Apr 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$72.8k 1,367 shares
$53.22
$37.50
Coll Crespo Blas CHIEF MEDICAL OFFICER
Holding Value $10.5M 280,878 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.57M 169,881 shares
$50.46
$37.50
Yoon Jun CHIEF FINANCIAL OFFICER
Holding Value $52.6M 1,401,656 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.8M 232,977 shares
$50.46
$37.50
Hall Ashley Chief Development Officer
Holding Value $5.82M 155,187 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.39M 106,779 shares
$50.46
$37.50
Stevens Raymond C CHIEF EXECUTIVE OFFICER
Holding Value $52.6M 1,401,593 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.4M 582,447 shares
$50.46
$37.50
Lin Xichen CHIEF SCIENTIFIC OFFICER
Holding Value $8.59M 228,960 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.9M 97,071 shares
$50.46
$37.50
Ma Yingli CHIEF TECHNOLOGY OFFICER
Holding Value $5.25M 139,917 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.67M 72,804 shares
$50.46
$37.50
Love Ted W Director
Holding Value $1.94M 51,804 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 51,804 shares
$22.10
$37.50
Dobmeier Eric Director
Holding Value $1.94M 51,804 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 51,804 shares
$22.10
$37.50
Russell Angus C. Director
Holding Value $1.61M 42,833 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$947k 42,833 shares
$22.10
$37.50
Holding Value $1.94M 51,804 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 51,804 shares
$22.10
$37.50
Welch Daniel G Director
Holding Value $1.94M 51,804 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 51,804 shares
$22.10
$37.50
Tetlow Sharon Director
Holding Value $1.94M 51,804 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 51,804 shares
$22.10
$37.50
Bach Mark Allen CHIEF MEDICAL OFFICER
Holding Value $2.45M 65,352 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.3M 65,352 shares
$35.25
$37.50
Farid Ramy Director
Holding Value $0 0 shares
Last Trade
Feb 07, 2023 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$15.5M 642,245 shares
$24.12
$37.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up